Epigenetic targeting of glioma stem cells: Short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity
- 9 March 2016
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 35 (5) , 2811-2824
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 53 references indexed in Scilit:
- Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamicsProceedings of the National Academy of Sciences, 2013
- Glioblastoma Cancer Stem-Like CellsThe Cancer Journal, 2012
- Epigenetic-Based Therapies in CancerDrugs, 2011
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applicationsImmunology & Cell Biology, 2011
- Epigenetic aberrations during oncogenesisCellular and Molecular Life Sciences, 2011
- Molecular Epigenetics and Genetics in Neuro-OncologyNeurotherapeutics, 2009
- Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolutionOncogene, 2009
- Epigenetics in CancerNew England Journal of Medicine, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Antitumor activity of sodium valproate in cultures of human neuroblastoma cellsAnti-Cancer Drugs, 1996